Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories

Virchows Archiv

Volumn 441, Issue 4, 2002, Pages 328-334

  Regitnig, Peter ^a   Reiner, Angelika ^b   Dinges, Hans Peter ^c   Höfler, Gerald ^a   Müller Holzner, Elisabeth ^d   Lax, Sigurd F ^a   Obrist, Peter ^e   Rudas, Margaretha ^f   Quehenberger, Franz ^g  

^a UNIVERSITY OF GRAZ   (Austria)

^b DANUBE HOSPITAL   (Austria)

^c GENERAL HOSPITAL KLAGENFURT   (Austria)

^d Morphologisches Labor   (Austria)

^e MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^f UNIVERSITY OF VIENNA   (Austria)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Breast carcinoma; Estrogen and progesterone receptor; External quality assurance; Immunohistochemistry; Reproducibility; Steroid hormone receptor status

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; AUSTRIA; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY; MOLECULAR BIOLOGY; OBSERVER VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SCORING SYSTEM;

AUSTRALIA; BREAST NEOPLASMS; CARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; PATHOLOGY; QUALITY ASSURANCE, HEALTH CARE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; SOCIETIES, MEDICAL;

EID: 0036912509     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-002-0646-5     Document Type: Article

References (25)

1. Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohisto-chemical analysis. Mod Pathol 11:155-168
2. Bast RC, Jr. Ravdin P, Hayes DF, Bates S, Fritsche H, Jr. Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR (2001) 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865-1878
3. De Mascarel I, Soubeyran I, MacGrogan G (1995) Immunohistochemical analysis of estrogen receptors in 938 breast carcinomas. Concordance with biochemical assay and prognostic significance. Appl Immunohistochem 3:222-231
4. Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 351:1451-1467
5. Ferno M, Andersson C, Fallenius G, Idvall I (1996) Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment. The South Sweden Breast Cancer Group. Acta Oncol 35:17-22
6. Fleiss JG (1981) Statistical Methods for Rates and Proportions. Wiley, New York, NY, pp 225-232
7. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474-1481
8. Jaiyesimi IA, Buzdar AU, Decker DA, Hortobagyi GN (1995) Use of tamoxifen for breast cancer: Twenty-eight years later. J Clin Oncol 13:513-529
9. Jakesz R, Hausmaninger H, Haider K, Kubista E, Samonigg H, Gnant M, Manfreda D, Tschurtschenthaler G, Kolb R, Stierer M, Fridrik M, Mlineritsch B, Steindorfer P, Mittlbock M, Steger G (1999) Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer. J Clin Oncol 17:1701-1709
10. Kell DL, Kamel OW, Rouse RV (1993) Immunohistochemical analysis of breast carcinoma estrogen and progesterone receptors in paraffin-embedded tissue, correlation of clones ER1D5, and 1A6 with cytosol-based hormone receptor assay. Appl Immunohistochem 1:275-281
11. Kohlberger PD, Breitenecker F, Kaider A, Losch A, Gitsch G, Breitenecker G, Kieback DG (1999) Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: A comparison. Anticancer Res 19:2189-2193
12. Landis JR, Koch GG (1977) The measurement of observer agreement for categorial data. Biometrics 33:159-174
13. Pertschuk LP, Feldman JG, Kim YD, Braithwaite L, Schneider F, Braverman AS, Axiotis C (1996) Estrogen receptor immu-nocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based li-gand-binding assays. Cancer 77:2514-2519
14. Pritchard KI (2000) Current and future directions in medical therapy for breast carcinoma: Endocrine treatment. Cancer 88:3065-3072
15. Reiner A, Spona J, Reiner G, Schemper M, Kolb R, Kwasny W, Fugger R, Jakesz R, Holzner JH (1986) Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and im-munohistochemical methods using monoclonal antireceptor antibodies. Am J Pathol 125:443-449
16. Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R (1990) Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 50:7057-7061
17. Remmele W (1997) Pathologie, 2nd Edn, vol 4. Springer, Berlin Heidelberg New York, p 259
18. Remmele W, Schicketanz KH (1993) Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 189:862-866
19. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohisto-chemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138-140
20. Remmele W, Hildebrand U, Hienz HA, Klein PJ, Vierbuchen M, Behnken LJ, Heicke B, Scheidt E (1986) Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch 409:127-147
21. Rhodes A, Jasani B, Balaton AJ, Miller KD (2000) Immuno-histochemical demonstration of oestrogen and progesterone receptors: Correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol 53:292-301
22. Rhodes A, Jasani B, Barnes DM, Bobrow LG, Miller KD (2000) Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: Interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol 53:125-130
23. Rhodes A, Jasani B, Balaton AJ, Barnes DM, Anderson E, Bobrow LG, Miller KD (2001) Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Am J Clin Pathol 115:44-58
24. Vargas HI, Agbunag RV, Khaikhali I (2000) State of the art of minimally invasive breast biopsy: principles and practice. Breast Cancer 7:370-379
25. Zafrani B, Aubriot MH, Mouret E, De Cremoux P, De Rycke Y, Nicolas A, Boudou E, Vincent-Salomon A, Magdelenat H, Sastre-Garau X (2000) High sensitivity and specificity of immu-nohistochemistry for the detection of hormone receptors in breast carcinoma: Comparison with biochemical determination in a prospective study of 793 cases. Histopathology 37:536-545